NEW YORK, July 14 - In testimony before the Joint Economic Committee of the US Congress last week, FDA Commissioner Mark McClellan warned that innovative biomedical technologies such as genomics, proteomics, and bioinformatics may lead to an increase in the overall costs of healthcare, but noted that "the potential benefits of new treatments could grow even more dramatically."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.